Langsjoen PH, Langsjoen AM. “Overview of the use of CoQ10 in cardiovascular disease.” Biofactors. 1999. PMID: 10416041.
Swaminathan R. “Magnesium metabolism and its disorders.” Clin Biochem Rev. 2003. PMID: 18568054.
Arendse L, et al. “Potassium in cardiovascular disease.” J Hypertens. 2013. PMID: 23337520.
Frishman, W.H. “Beta-Adrenergic Blockers: A Class Update” – American Journal of Therapeutics, 2008.
McGill, J.B., et al. “Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Patients with Renal Impairment” – Journal of Clinical Pharmacology, 1990.
Gold, P. “Bisoprolol Fumarate for the Treatment of Hypertension and Angina Pectoris” – American Journal of Cardiology, 1986.
Dimsdale, J.E., et al. “Effects of Beta-Blockers on Serum Lipids and Lipoproteins: A Review” – American Heart Journal, 1991.
Bailey, D.G., et al. “Grapefruit Juice-Drug Interactions” – British Journal of Clinical Pharmacology, 1998.
Izzo, A.A., et al. “Interactions between Herbal Medicines and Prescribed Drugs: An Updated Systematic Review” – Drugs, 2009.
Holick, M.F. “Vitamin D and Cardiovascular Disease” – Annals of Epidemiology, 2009.
Rosanoff, A., Weaver, C.M., Rude, R.K. “Suboptimal Magnesium Status in the United States: Are the Health Consequences Underestimated?” – Nutrition Reviews, 2012.